GROUP | PPP (days) | PP (days) | SURVIVAL (days) | DEATH n/N (%) |
---|
CI | 6.02±1.85 | 9.63±2.74 | 15.33±3.39 | 12/12 (100%) |
BIOT4-5-6 | 3.86±1.36* | 7.43±1.99* | 12.14±1.25* | 12/12 (100%) |
BIOT7-8-9 | 4.38±1.32* | 8.88±1.62 | 14±1.5 | 12/12 (100%) |
BIOTPI | 13.67±33.11 | 6.61±2.69** | 29±42.79 | 10/12 (83%) |
BIOT4PI | 21.5±42.87** | 5.78±1.03** | 27.1±40.98** | 11/12 (92%) |
- Statistical significance (p < 0.05* and p < 0.01**) compared to control group: CI: control group – infected animals treated with 7% ethanol-water solution diluted in water (10μL/mL) offered ad libitum; BIOTPI: infected animals treated with biotherapic BIOTTc 17dH diluted in water (10μL/mL) offered ad libitum from the day of the infection until the death of the animals; BIOT4PI: infected animals treated with biotherapic BIOTTc 17dH diluted in water (10μL/mL) offered ad libitum from the 4th day of the infection until the death of the animals; BIOT4-5–6: infected animals treated with biotherapic BIOTTC 17dH by gavage on the 4th, 5th and 6th day of the infection; BIOT7-8–9: infected animals treated with biotherapic BIOTTC 17dH by gavage on the 7th, 8th and 9th day of the infection.